Evidence map›Paper›PMID 37588789›Full record

ArticleBJA open2022

Circulating oxylipin and bile acid profiles of dexmedetomidine, propofol, sevoflurane, and S-ketamine: a randomised controlled trial using tandem mass spectrometry.

Aleksi Nummela, Lauri Laaksonen, Annalotta Scheinin, Kaike Kaisti, Tero Vahlberg, Mikko Neuvonen, Katja Valli, Antti Revonsuo, Markus Perola, Mikko Niemi and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BJA open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02624401 (The Neural Mechanisms of Anesthesia and Human Consciousness), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02624401 phase4completednot on this map

The Neural Mechanisms of Anesthesia and Human Consciousness (Part 6)

TypeinterventionalSponsorUniversity of TurkuRan2016 to 2017Enrolled160ConditionsAnesthesia, UnconsciousnessArmsDexmedetomidine, Propofol, S-ketamine, Sevoflurane, Placebo
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Aleksi NummelaTurku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
Lauri LaaksonenTurku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
Annalotta ScheininTurku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
Kaike KaistiTurku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
Tero VahlbergDepartment of Clinical Medicine, Biostatistics, Intensive Care and Pain Medicine, University of Turku and Turku University Hospital, Turku, Finland.
Mikko NeuvonenDepartment of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
Katja ValliDepartment of Peri-operative Services, University of Turku and Turku University Hospital, Turku, Finland.
Antti RevonsuoDepartment of Psychology and Speech-Language Pathology, and Turku Brain and Mind Center, University of Turku, Turku, Finland.
Markus PerolaDepartment of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
Mikko NiemiDepartment of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.
Harry ScheininTurku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
Timo LaitioDepartment of Peri-operative Services, University of Turku and Turku University Hospital, Turku, Finland.
University of Turku · FITurku PET Centre · FITurku University Hospital · FIUniversity of Helsinki · FIFinnish Institute for Health and Welfare · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This exploratory study aimed to investigate whether dexmedetomidine, propofol, sevoflurane, and S-ketamine affect oxylipins and bile acids, which are functionally diverse molecules with possible connections to cellular bioenergetics, immune modulation, and organ protection. Methods: In this randomised, open-label, controlled, parallel group, Phase IV clinical drug trial, healthy male subjects ( Results: Statistically significant changes Conclusions: Dexmedetomidine-induced oxylipin alterations may be connected to pathways associated with organ protection. In contrast to dexmedetomidine, propofol emulsion elevated DiHOMEs, oxylipins associated with acute respiratory distress syndrome, and mitochondrial dysfunction in high concentrations. Further research is needed to establish the behaviour of DIHOMEs during prolonged propofol/dexmedetomidine infusions and to verify the sevoflurane-induced reduction in TUDCA, a suggested neuroprotective agent. Clinical trial registration: NCT02624401.

Indexed as

bile acidsdexmedetomidinelipidomicsoxylipinspropofolsevofluraneS-ketamine

Identifiers

PMID37588789
PMCPMC10430865
OpenAlexW4312056359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.